Table 2.
Primary brain vs. | Other primary tumors | Brain metastases | ||||
---|---|---|---|---|---|---|
P‐value† | fold‐change‡ | AUC | P‐value† | fold‐change‡ | AUC | |
hsa‐miR‐124 | 1.4E‐54 | 97.1 | 0.9975 | 5.4E‐06 | 12.6 | 0.8600 |
hsa‐miR‐219‐5p | 9.7E‐43 | 10.0 | 0.9679 | 4.1E‐09 | 6.9 | 0.8840 |
C0 † | 1.8E‐49 | 293.0 | 1.0000 | 9.0E‐09 | 27.7 | 0.8987 |
hsa‐miR‐128 | 5.4E‐27 | 9.3 | 0.9929 | 4.5E‐11 | 4.2 | 0.9507 |
hsa‐miR‐9* | 1.4E‐64 | 31.3 | 1.0000 | 9.1E‐22 | 18.9 | 0.9933 |
hsa‐miR‐92b | 1.8E‐26 | 7.3 | 0.9993 | 2.1E‐18 | 5.8 | 1.0000 |
C1 † | 1.7E‐57 | 205.9 | 1.0000 | 3.3E‐26 | 128.7 | 1.0000 |
P‐values are calculated on log‐signal of microRNAs, and on C0 and C1 (methods), which are in log‐space. Less that 1000 probes were tested, and even after the more severe Bonferroni correction (multiplying each P‐value by ∼1000), the P‐values remain highly significant.
The fold change is calculated by dividing the median signal in brain primary tumors by the median signal in other tissues.